ELI LILLY & Co — Director's Dealing 2025

Aug 12, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2025-08-12

Reporting Person: Ricks David A (Director, President, Chair, and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-12	Common Stock	P	1632	$644.769	Acquired	546601.167	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	54117	Indirect
Common Stock	300	Indirect
Common Stock	68656	Indirect
Common Stock	7295.84	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $644.45 to $645.11, inclusive. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2: Includes 16 shares previously held in a family member's retirement account.

F3: On May 15, 2025, 5,340 shares of Eli Lilly and Company common stock were transferred to the reporting person as an annuity payment in accordance with the terms of the Grantor Retained Annuity Trust, of which the reporting person is the trustee.

F4: The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.